Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Inhibition of complement mediated inflammatory response using monoclonal antibodies specific for a component forming the C56-9 complex which inhibit the platelet or endothelial cell activating function of the C56-9 complex

US Patent 5635178 · Granted Jun 3, 1997

Assignee

Inventors

View full patent text on Google Patents →